Decitabine and haemorrhage intracranial Patient Reports February 12, 2012



Decitabine Side Effects Report #5572433-1
Decitabine side effect was reported by a Physician from ISRAEL on Dec 06, 2007. Female patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: confusional state, haematoma, haemorrhage intracranial, subdural haematoma, vomiting. Decitabine dosage: 30 MG, INTRAVENOUS. During the same period patient was treated with GLUCOPHAGE. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5328352-9
Decitabine side effect was reported by a Physician from TURKEY on May 07, 2007. Female patient, 64 years of age, weighting 163.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, diarrhoea, haemoglobin decreased, haemorrhage intracranial, hypotension, liver function test abnormal, neutropenia, prothrombin time prolonged. Decitabine dosage: 15 MG/M**2; Q8H; IV. During the same period patient was treated with DEFEROXAMINE MESYLATE. Patient was hospitalized. Patient died on 03/22/2007.

Decitabine Side Effects Report #5663712-8
Decitabine side effect was reported by a Physician from GERMANY on Feb 26, 2008. Female patient, 63 years of age, weighting 229.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: fall What is  fall, haematuria, haemorrhage intracranial, infection What is  infection, pneumonia What is  pneumonia, subarachnoid haemorrhage, subdural haematoma. Decitabine dosage: 270 MG, IN 1 TOTAL, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, ACYCLOVIR, SEMPERA, ANTI FUNGAL. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5565820-9
Decitabine side effect was reported by a Physician from TURKEY on Dec 05, 2007. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspiration tracheal abnormal, bacterial infection What is  bacterial infection, blood culture positive, caecitis, febrile neutropenia, haemorrhage intracranial, hepatic function abnormal, prothrombin time prolonged. Decitabine dosage: 225 MG, INTRAVENOUS. During the same period patient was treated with PIPERACILLIN TAZOBACTAM, AMIKACIN, PRIMAXIN, NETILMICIN SULPHATE, DEFEROXAMINE. Patient was hospitalized and became disabled. Patient died on 03/22/2007.


Decitabine Side Effects Report #5567424-0
Decitabine side effect was reported by a Physician from TURKEY on Dec 05, 2007. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, bacterial infection What is  bacterial infection, caecitis, febrile neutropenia, haemorrhage intracranial, hepatic function abnormal, prothrombin time prolonged, pseudomonas infection, renal impairment. Decitabine dosage: 225 MG, INTRAVENOUS. During the same period patient was treated with PIPERACILLIN TAZOBACTAM, AMIKACIN, PRIMAXIN, NETILMICIN SULPHATE, DEFEROXAMINE. Patient was hospitalized and became disabled. Patient died on 03/22/2007.

Decitabine Side Effects Report #5657879-5
Decitabine side effect was reported by a Physician from TURKEY on Feb 22, 2008. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, disease progression, febrile neutropenia, fibrin d dimer increased, haemorrhage intracranial, liver function test abnormal, platelet count decreased, prothrombin time prolonged. Decitabine dosage: 225 MG, INTRAVENOUS. During the same period patient was treated with PIPERACILLIN TAZOBACTAM, AMIKACIN, PRIMAXIN, NETILMICIN SULPHATE, DEFEROXAMINE. Patient was hospitalized and became disabled. Patient died on 03/22/2007.

Decitabine Side Effects Report #5729578-2
Decitabine side effect was reported by a Physician from TURKEY on Apr 22, 2008. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, disease progression, febrile neutropenia, haemoglobin decreased, haemorrhage intracranial, hepatic function abnormal, multi-organ failure, platelet count decreased. Decitabine dosage: 225 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 03/22/2007.

Decitabine Side Effects Report #5739590-5
Decitabine side effect was reported by a Physician from TURKEY on May 02, 2008. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, haemoglobin decreased, haemorrhage intracranial, hepatic function abnormal, hypotension, loss of consciousness, multi-organ failure, neutropenia. Decitabine dosage: 225 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 03/22/2007.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Decitabine